number changes with reproductive status. While it has been suggested that brain mast cells contain the mammalian hypothalamic form of gonadotropin-releasing hormone (GnRH-I), it is not known whether mast cells synthesize GnRH-I de novo. In the present study, mast cells in the rat thalamus were immunoreactive to antisera generated against GnRH-I and the GnRH-I associated peptide (GAP); mast cell identity was confirmed by the presence of heparin, a molecule specific to mast cells, or serotonin. To test whether mast cells synthesize GnRH-I mRNA, in situ hybridization was performed using a GnRH-I cRNA probe, and the signal was identified as being within mast cells by the binding of avidin to heparin. GnRH-I mRNA was also found, using RT-PCR, in mast cells isolated from the peritoneal cavity. Given the function of GnRH-I in the regulation of reproduction, changes in the population of brain GnRH-I mast cells were investigated. While housing males with sexually receptive females for 2 h or 5 days resulted in a significant increase in the number of brain mast cells, the proportion of mast cells positive for GnRH-I was similar to that in males housed with a familiar male. These findings represent the first report showing that mast cells synthesize GnRH-I and that the mast cell increase seen in a reproductive context is the result of a parallel increase in GnRH-I positive and non-GnRH-I positive mast cells.
INTRODUCTION
Mast cells are bone marrow-derived multifunctional immune cells. In peripheral tissues mast cells have well-established roles in mediating inflammation and allergic responses and in providing immunity against parasites (Wasserman, 1989; Galli, 1993; Metcalfe et al., 1997) . Mast cells also participate in defense against bacterial infection (Wedemeyer et al., 2000; Malaviya and Abraham, 2001) .
Mast cells occur in the adult brain in both health and disease (Silver et al., 1996) . In mammals, mast cells are found in the dura mater, meninges, and choroid plexus, and at perivascular locations and within the neural parenchyma in the thalamus (Dropp, 1972; Theoharides, 1990; Manning et al., 1994; Florenzano and Bentivoglio, 2000) . In the murine model of multiple sclerosis (MS), experimental allergic encephalomyelitis (EAE), mast cells are found in proximity of MS plaques and play a role in the pathophys-iology of this disease (Bebo et al., 1996; Secor et al., 2000) .
Mature mast cells contain granules that store preformed effector molecules such as histamine, serotonin, serine proteases, exopeptidases, and neuropeptides . When activated, mast cells release these granules in a process referred to as compound exocytosis or degranulation (Dvorak, 1991) . Activation of mast cells also triggers de novo synthesis and secretion of leukotrienes, prostaglandins, cytokines, and chemotactic factors, which exert profound effects on the local microenvironment . Mast cells accumulate diverse molecules and particles by endocytosis (e.g., antigen-aggregated IgE) (Furuichi et al., 1986) , via high affinity uptake transporters (e.g., serotonin) (Chen et al., 2001 ) and by phagocytosis (e.g., bacteria and latex beads) (Czarnetzki, 1982) .
Gonadotropin releasing hormone (GnRH-I) immunoreactive (IR) mast cells were found in the dove and mouse brain (Silverman et al., 1994b; Yang et al., 1999) . This neurohormone regulates the hypothalamic-pituitary-gonadal (HPG) axis and hence, reproduction. In the mammalian brain, GnRH-I neurons lie in a continuum in the medial septal, preoptic, and hypothalamic areas (Silverman et al., 1994a) . GnRH-I is also expressed in peripheral organs such as the gonads and placenta (Khodr and Siler-Khodr, 1980; Oikawa et al., 1990; Peng et al., 1994) , where it serves a variety of functions including regulation of steroid production in the gonads and tissue remodeling during implantation, among others.
The specific set of mediators produced by mast cells differs according to their activational stage, locale, and immune status of their microenvironment Galli, 1990; Friend et al., 1996) . In addition, the number of mast cells in the brain changes in response to various behavioral stimuli. In the ringdove, courtship is associated with a dramatic increase in GnRH-I-IR mast cells in the medial habenula of the epithalamus (Zhuang et al., 1993) . Moreover, an increase in mast cell number and in the proportion of activated mast cells occurs in the medial habenula following treatment with gonadal steroids . In rats, cohabitation of a male with a sexually receptive female elicits an increase in the number of mast cells in dorsal thalamic nuclei , as does mating followed by cohabitation of male mice with a female (Yang et al., 1999 ). An increase in thalamic mast cells was also found in postpartum female rats separated from their pups compared to age-matched virgin controls , though this phenomenon may be due to nonreproductive parameters such as stress (Esposito et al., 2001 ).
Mast cell migration to tissues and degranulation therein is a mechanism of delivery of bioactive substances to specific sites in the body. The presence of GnRH-I in brain mast cells may point to a novel functional role of this neuropeptide. In the present study, we sought to determine if GnRH-I immunoreactivity in brain mast cells is due to its in situ synthesis. We then examined whether the number of brain mast cells and the proportion of GnRH-I-IR mast cells in the total population are influenced by a reproductive context.
MATERIALS AND METHODS

Experimental Protocol
Subjects were sexually naive adult male Long-Evans rats (Charles River Laboratories, Wilmington, MA) housed two/ cage in a temperature-and humidity-controlled environment for at least 2 weeks before the start of experiments. The animals were maintained on a 12:12 h light/dark cycle (lights off 1900h) and were provided with food and water ad libitum. Males were paired with sexually receptive stimulus females for 2 h (n ϭ 8; MϩF, 2 h) or 5 days (n ϭ 5; MϩF, 5 d). Males that were housed with a familiar male (n ϭ 8; MϩM) served as controls.
Sexual receptivity was induced in ovariectomized females by s.c. injections of 10 g estradiol 3-benzoate (E; Sigma, St. Louis, MO) at 12 pm on day 1 and 2 and 500 g progesterone (P; Sigma) at 9 am on day 4 (Schumacher et al., 1991) , and verified by testing manually for lordosis response 4 h after progesterone treatment. Paired animals were observed for 30 min, and only males whose female partner displayed lordosis, darting, and ear wiggling when approached by the males were used as subjects. Additional animals for immunocytochemical experiments as well as for in situ hybridization and RT-PCR analyses are indicated below.
Perfusion, Immunocytochemistry, and Histochemistry
Male rats were deeply anesthetized with a 1 mL i.p. injection of sodium pentobarbital (50 mg/mL; Henry Schein, Melville, NY) and were perfused transcardially with 100 mL of 0.9% saline followed by 300 mL of 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.3, all at room temperature. Brains were postfixed for 2 h and cryoprotected in 20% sucrose/phosphate buffer/0.1% sodium azide at 4°C.
Serial coronal sections (50 m) were cut on a cryostat (Zeiss Microm HM 500 OM; Walldorf, Germany). All procedures described below were carried out at room temperature unless otherwise indicated.
Sections were viewed on a conventional/fluorescent microscope (Nikon Eclipse E800; Nikon, Inc., Melville, NJ), and images were captured using a SPOT cooled CCD cam-era (Diagnostic Instruments, Inc., Sterling Heights, MI). For scanning confocal fluorescence microscopy, images were captured using LSM 410 (Zeiss, Inc., Thornwood, NJ), with differential interference contrast (DIC) optics.
Mast Cell Markers. Histochemical detection of mast cells was accomplished by staining sections with acidic toluidine blue (TB) [0.2% Toluidine Blue O (Sigma), pH 2.0], which reacts with the sulfated proteoglycans in mast cell granules, or with Cy2-conjugated avidin (1:500, 1 h; Jackson Immunoresearch Labs, West Grove, PA), which binds to heparin, a mast cell specific glycosaminoglycan (Kjellen and Lindahl, 1991) . In some experiments mast cell phenotype was confirmed by the presence of serotonin using an antibody raised in rabbit (1:5000; #20080 Lot 715499; Incstar, Stillwater, CA).
Immunocytochemistry: GnRH-I in Mast Cells. Identification of GnRH-I-IR brain mast cells was made using a polyclonal antiserum to GnRH-I (guinea pig anti-GnRH-I, 1:2000, incubated overnight; #JUP3040; Advanced ChemTech Inc., Louisville, KY); antigen was detected with Cy3-conjugated donkey anti-guinea pig immunoglobulin (1:200, 1 h; Jackson Immunoresearch Labs). The antiserum to serotonin (vide supra) was added to the GnRH-I antibody and detected using Cy2-conjugated donkey anti-rabbit.
GnRH-I Prohormone in Mast Cells.
Immunocytochemical localization of GnRH associated peptide (GAP), a segment of the GnRH-I prohormone (Kasten et al., 1996) , was performed using a polyclonal antiserum [rabbit anti-rat GAP (amino acids 14 -69); 1:2000, incubated overnight; IHC 7224; Peninsula Lab, Inc., Belmont, CA] and detected with Cy3-conjugated donkey anti-rabbit (1:200, 1 h; Jackson Immunoresearch Labs). The subjects were males paired with sexually receptive females for 5 days (n ϭ 2).
Positive (and negative) controls for GnRH-I-and GAPimmunoreactivity consisted of sections of the medial preoptic area (MPOA) and thalamus containing GnRH-I neuron cell bodies and mast cells, respectively, incubated in the presence (or absence) of the primary antibodies.
In Situ Hybridization
A digoxigenin-(DIG) labeled antisense cRNA probe comprising exons 1 through 4 of rat GnRH-I was generated using GnRH-I cDNA graciously provided by Dr. James Roberts and the MAXIscript™ in vitro transcription kit (Ambion, Inc., Austin, TX). In situ hybridization was performed as described previously (Hamada et al., 1999) on free-floating 30 m serial sections collected through the extent of the hypothalamus and thalamus (bregma 1.6 mm to Ϫ6.0 mm; n ϭ 3; MϩF, 5 d) (Paxinos and Watson, 1986) . The negative control consisted of omitting the antisense probe during the hybridization step; GnRH-I producing neurons in the MPOA served as a positive control. The sense probe was not used because the GnRH gene locus encodes a second gene (termed SH) that is transcribed from the opposite strand (Adelman et al., 1987) , producing SH mRNA in the hypothalamus (Bond et al., 1989) . Following hybridization and signal detection, the sections were incubated with avidin-Cy2. To distinguish the DIG signal from the mast cell nucleus, sections were counterstained for 10 min with 10 Ϫ5 M 4,6 diamidino-2-phenylindole (DAPI; Sigma), a DNA-binding fluorescent dye.
RT-PCR
Peritoneal mast cells were chosen for RT-PCR as their phenotype resembles that of brain mast cells (Pang et al., 1996) . Mast cells from the peritoneal cavity of male rats (n ϭ 3) were isolated as previously described (Jippo et al., 2001) . Briefly, male rats were deeply anesthetized and the peritoneal cavity was flushed with 30 mL of Tyrode's buffer (23°C, pH ϭ 7.4). Mast cells were separated by two successive centrifugations through a 22.5% (w/v) metrizamide gradient (density 1.12 g/mL, 400ϫg, 15 min; Sigma) in Tyrode's buffer containing 0.1% gelatin. A Ͼ99% pure population of mast cells was obtained as confirmed by staining with TB. Total RNA from peritoneal mast cells was extracted using the RNAqueous™-4PCR kit (Ambion). The RNA (0.5 g) was then reverse transcribed using oligo(dT) primers and reverse transcriptase (RETROscript™ Kit, Ambion). Rat GnRH-I, Carboxypeptidase A (CPA), a mast cell specific exopeptidase (Reynolds et al., 1989) , which was used as a positive control, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA were PCR-amplified using the following primer pairs: 5Ј-TCC CTT TGG CTT TCA CAT CC-3Ј and 5Ј-TGC CAT TTG ATC CTC CTC CT-3Ј for GnRH-I, 5Ј-CAA TCA AAC TGC CAC CCA AC-3Ј and 5Ј-ACG AAG CTC AAA GGC AAA TG-3Ј for CPA, and 5Ј-TGC GAC TTC AAC AGC AAC TC -3Ј and 5Ј-CAG CAA GGA CAC TGA GCA AG-3Ј for GAPDH. Negative controls consisted of using RNA that was not reverse transcribed, which ensured that the samples were devoid of genomic DNA contamination. PCR was also performed in the absence of template DNA, which tested contamination in samples and reagents. To verify the sequence identity of the amplicons, the PCR products were sequenced directly using an ABI 3100 capillary sequencer (Applied Biosystems, Foster City, CA), and the sequences were aligned with the GnRH-I mRNA (GI: 6980967; Adelman et al., 1986) and CPA precursor mRNA (GI: 1698707; Lutzelschwab et al., 1997) sequences in the NCBI Entrez Nucleotides database using the pairwise BLAST program (Altschul et al., 1990) .
Analysis of Mast Cell Numbers and Localization
Mast cells with visible nuclei were counted in TB-stained sections spanning the thalamus (bregma Ϫ0.05 mm to Ϫ5.9 mm) and mapped according to the atlas of Paxinos and Watson (1986) , as previously reported . Groups included MϩM (n ϭ 8), MϩF 2 h (n ϭ 8), and MϩF 5 d (n ϭ 5), as described above. Every second or third section was counted, and the number of cells was estimated using the Abercrombie correction factor (Abercrombie, 1946) .
The proportion of GnRH-I-IR mast cells in the same experimental groups was determined in alternate sections through the midthalamus (bregma Ϫ2.66 to Ϫ3.64 mm) by calculating the number of double-labeled (GnRH-I-and serotonin-positive) compared to serotonin-positive mast cells. One-way ANOVA was used to determine significant differences in mast cell number among groups, followed by a t test to compare mast cell counts between individual groups.
RESULTS
Rat Brain Mast Cells Are IR for GnRH-I and GAP
Thalamic mast cells were IR for GnRH-I [ Fig. 1(A) ], and mast cell phenotype was confirmed by doublelabeling with an antibody to serotonin [ Fig. 1(B,C) ]. All of the GnRH-I-IR mast cells contained serotonin, but the converse was not true (see below). Confocal microscopy revealed that GnRH-I and serotonin were sometimes, but not always, in the same mast cell granule [ Fig. 1(C) ]. When primary antisera were omitted no GnRH-I-IR neurons or mast cells were seen (data not shown).
A subset of mast cells was IR for GAP, a fragment of the GnRH-I prohormone peptide [ Fig. 1(D,G) ]. GAP-IR was colocalized with the mast cell marker heparin as evidenced by the binding of avidin-Cy2 [ Fig. 1(D-I) ]. As with GnRH-I, GAP-IR was seen in some, but not all mast cell granules. GAP antiserum labeled GnRH-I neurons in the MPOA (not shown) and axons in the median eminence [ Fig. 1(G) ]. Avidin-Cy2 labeled mast cells but not GnRH-I neurons or their processes [ Fig. 1(H,I) ].
Mast Cells in the Brain Contain GnRH-I mRNA
In situ hybridization with a DIG-labeled GnRH-I cRNA probe revealed GnRH-I mRNA in neurons in MPOA [ Fig. 2(A) ] and in mast cells in the thalamus [ Fig. 2(B,D,E,H) ]. The mast cell phenotype was verified by the binding of avidin-Cy2 [ Fig. 2(C,F) ], and colocalization of DIG signal with avidin was shown using confocal fluorescence microscopy and DIC optics [ Fig. 2(B-D) ]. The DIG signal in the cell is located in the cytoplasm, above the DAPI-stained nucleus [ Fig. 2(E-H) ]. No background staining was detected in these sections. No signal was observed in sections in which probe was omitted (data not shown).
Peritoneal Mast Cells Express GnRH-I mRNA
Amplification of GnRH-I, CPA, and GAPDH mRNA [ Fig. 3(B,C) ] was obtained by RT-PCR of purified peritoneal mast cells [ Fig. 3(A) ]. Lymphocytes were not seen in the peritoneal mast cell preparation. Alignment of the mRNA sequence obtained from the RT-PCR amplification of peritoneal mast cells using GnRH primers to the published rat GnRH-I sequence showed that it was identical to that of GnRH-I neurons (not shown). The sequence obtained using CPA specific primers was identical to the published sequence (not shown). Mast cells isolated from the peritoneal cavity were also IR for GnRH-I (data not shown).
Behavioral State Influences Brain Mast Cells
The thalami of males paired with sexually receptive females for 2 h or 5 days had more TB-positive (TBϩ) mast cells compared to males housed with familiar males [p ϭ 0.017; Fig. 4(A) ], extending our previous observations . This statistically significant increase in the mast cell population was confined to the midthalamic region (AP Ϫ2.66 to Ϫ3.64 mm) encompassing the centromedial (CM), centrolateral (CL), paracentral (PC), posterior (Po), ventrolateral (VL), ventral posterolateral (VPL), and ventral posteromedial (VPM) nuclei [ Fig. 4(A) ]. A similar increase was documented using serotonin immunocytochemistry [ Fig. 4(B) ].
GnRH-I-IR mast cells had a similar distribution to the entire mast cell population [ Fig. 4(B) ]. GnRH-I-IR mast cells also increased in the midthalamus when males cohabited with females [p ϭ 0.036; Fig. 4(C) ]. The number of GnRH-I-IR mast cells increased in proportion to the overall population [ Fig. 4(D) ].
Occasional TBϩ and GnRH-I-IR mast cells were present in the median eminence in all three groups [ Fig.  1(G-I) ]. The change in the average number of TBϩ mast cells in this area in MϩM, MϩF 2 h, and MϩF 5 day approached significance (30.5 Ϯ 9.0, 65.2 Ϯ 19.4, and 12.4 Ϯ 7.7, respectively; one-way ANOVA: p ϭ 0.064).
DISCUSSION
It has previously been reported that brain mast cells are GnRH-I-IR in doves and mice (Zhuang et al., 1993; Yang et al., 1999) ; however, this work did not reveal whether mast cells synthesize GnRH-I or whether the peptide enters the mast cell granule by an endocytotic mechanism. The present study demonstrates that mast cells in the rat brain and in the peritoneal cavity synthesize GnRH-I. This finding is particularly interesting as the number of mast cells in the brain increases coincident with reproductive behavior (Silver et al., 1992; Zhuang et al., 1993; Silverman et al., 1994b) and treatment with gonadal steroids in doves , mating and cohabitation in mice (Yang et al., 1999) , and sexual and social stimuli from conspecifics in rats . Consistent with previous findings, the increase in brain mast cells is rapid, is limited to specific nuclei in the dorsal thalamus, and is influenced by the stimulus condition presented by an opposite sex conspecific. A novel aspect revealed in the present work is that the proportion of GnRH-I-IR mast cells is constant irrespective of the behavioral state of the animal.
Brain Mast Cells Synthesize GnRH-I
The current experiments provide several lines of evidence that rat mast cells synthesize GnRH-I. First, brain mast cells are IR to antisera raised against the GnRH-I decapeptide. Second, and more importantly, these mast cells are also IR to antisera against GAP (a segment of the GnRH-I prohormone), suggesting that the protein is produced within the cell. It is unlikely that the immunoreactivity is due to GnRH-II, a second form of the neuropeptide encoded by a different gene, which is also found in rats and mice (Chen et al., 1998) , as the GnRH-I GAP sequence (as demonstrated for tree shrew and human) is highly divergent from the GAP sequence of GnRH-II (Kasten et al., 1996; White et al., 1998) . Third, the conclusion that mast cells synthesize GnRH-I is further supported by the in situ hybridization studies that employed a rat GnRH-I cRNA probe. Finally, RT-PCR of mRNA derived from peritoneal mast cells confirms that peripheral cells also synthesize GnRH-I. The GnRH-I mRNA sequence obtained from peritoneal mast cells is identical to that expressed by GnRH-I neurons. It is interesting to note that active forms of the GnRH-I peptide and mRNA are also synthesized by other hematopoietic cells, including lymphocytes and thymocytes (Emanuele et al., 1990; Azad et al., 1991; Maier et al., 1992; Chen et al., 1999) . It is possible that the GnRH-I mRNA amplification of the peritoneal mast cell preparation obtained by RT-PCR was due to the presence of contamination by other hematopoietic cells. The immunocytochemistry showing peritoneal mast cells labeled for GnRH-I further supports our conclusion that peripheral mast cells produce GnRH-I and extends previous ultrastructural studies showing GnRH-I immunoreactivity in the Golgi apparatus as well as in secretory granules of brain mast cells (Silverman et al., 1994b .
GnRH-I Functions Outside of the HPG Axis
A growing body of evidence indicates that GnRH-I acts outside of the HPG axis, influencing neuronal excitability, behavioral responses, and neuroimmune interactions. For example, GnRH-I can change the electrical activity of neurons in vivo and in vitro. This was first shown in frog sympathetic ganglia, in which a GnRH-like peptide is released upon stimulation and mediates a slow synaptic potential (Jan and Jan, 1982) . GnRH-I alters the firing pattern of neurons in the hippocampus (Palovcik and Phillips, 1986) , where it also induces a long-duration depolarization associated with increased input resistance, a reduction in the slow afterhyperpolarization (AHP), and a decrease in accommodation of CA1 neurons (Wong et al., 1990) . Application of the peptide to slices of the preoptic area or hypothalamic ventromedial nucleus causes a long latency, excitatory action potential, as well as a modulation of responses to other neurotransmitters such as norepinephrine (Jennes et al., 1997) . GnRH-I increases the excitability of olfactory receptor neurons in vitro by increasing the magnitude of a voltageactivated inward current (Eisthen et al., 2000) . GnRH-I can act in paracrine/autocrine fashion and can regulate its own release and receptor expression as shown in immortalized GnRH neurons (GT1-7 cells) (Krsmanovic et al., 1993) .
GnRH-I potentiates sexual behavior (Moss and McCann, 1973; Pfaff, 1973) . When infused into the midbrain central gray, GnRH enhances sexual receptivity in female rats (Sakuma and Pfaff, 1980) , even in hypophysectomized animals (Pfaff, 1973) .
GnRH-I also acts as an immunomodulator (Marchetti et al., 1989; Jacobson et al., 1994) . The action of GnRH-I as a mast cell activating molecule was discovered when GnRH-I and its analogues were used in the treatment of precocious puberty. Such treatment induced histamine secretion from mast cells, leading to cutaneous anaphylaxis (Sundaram et al., 1988; Rivier et al., 1986; Phillips et al., 1988) . For this reason, novel GnRH analogues for the treatment of this disorder have been designed to circumvent these adverse clinical effects (Jiang et al., 2001) . GnRH-I also stimulates lymphocyte proliferation (Marchetti et al., 1989; Morale et al., 1991) and interleukin-2 receptor expression Chen et al., 1999) . Finally, GnRH-I and -II stimulate expression of the laminin receptor in normal T cells, followed by their adhesion to laminin and chemotaxis toward SDF-1␣ in vitro. Both peptides enhance T cell migration and entry into specific organs in vivo (Chen et al., 2002) . Activated (degranulating) mast cells are found in the brain under normal physiological conditions (Theoharides et al., 1995; Florenzano and Bentivoglio, 2000; Wilhelm et al., 2000) . Release of mast cell granular contents into the brain parenchyma would make GnRH-I available in the thalamic nuclei where they are located (Florenzano and Bentivoglio, 2000; Asarian et al., 2002; present results) and in the median eminence (present study; Theoharides et al., 1995) . At these sites, mast cell derived GnRH-I could act in a paracrine fashion as a neuromodulator as postulated earlier following the discoveries of GnRH-I axons and terminals in many brain regions (see Silverman et al., 1994a) . It could also work in an autocrine manner modulating expression of cellular adhesion molecules and/or chemotaxis as in the case of T cells (Chen et ., 2002) . It is therefore of interest to determine whether mast cells express on their surface a receptor for GnRH. Excluding the medial habenula of the epithalamus, GnRH-I receptor/binding sites have not been reported in the thalamus (Jennes and Conn, 1994) . However, additional forms of GnRH receptors are being identified and one or more may be expressed in the thalamus (see review by Neill, 2002 ).
Brain Mast Cell Number
As in previous studies, the number of brain mast cells increases rapidly. The number of mast cells in the midthalamus of males following a 2 h exposure to a sexually receptive female is significantly greater than in males housed with familiar males. In doves, 2 h of courtship is sufficient to cause an increase in brain mast cells (Zhuang et al., 1993) . Similarly, in rats, vital dye-labeled mast cells can enter the brain in as little as 1 h following an intravascular injection . The increase in the mast cell population is apparently due to migration from the periphery, because no evidence of mast cell division was found using BrdU labeling . The mature granule content and mediator expression indicate that the mast cells identified in this and in prior studies are differentiated beyond the precursor stage (Rodewald et al., 1996) . Under normal conditions it is thought that mature mast cells do not circulate in the blood; hence, the source of this augmented population is likely to be via the pial sheath of the thalamic blood vessels (Lambracht-Hall et al., 1990; Manning et al., 1994) .
Proportion of GnRH-I Mast Cells Does Not Change with State
The phenotype of mast cells is regulated by their local microenvironment. Changes in expression of mast cell stimulating factors, such as the kit ligand (stem cell factor), nerve growth factor, and interleukin-3, -4, -9, and -10, alter the content of stored mediators produced by mast cells (Galli, 2000) . Therefore, the present study examined whether the proportion of thalamic mast cells containing GnRH-I varied with behavioral state. Although pairing of a male with a sexually receptive female increased the number of mast cells in the midthalamus, the proportion of cells that was GnRH-I-IR remained constant at 25% of the total across all states tested. This finding suggests that, at the time points tested, the expression of GnRH-I peptide in brain mast cells is not up-regulated and that the migration of mast cells from the periphery to the brain may not depend on their GnRH-I content or expression. These data also suggest that GnRH-I-IR mast cells are recruited into the same brain regions as other (e.g., serotonin containing) mast cells. However, there are two other possibilities: it is possible that only GnRH-I negative cells enter the CNS and once there activate GnRH-I synthesis. Alternatively, GnRH-I negative cells enter the CNS, but the resident thalamic mast cells start to express GnRH-I, thereby keeping the proportion constant.
In summary, the converging evidence derived from the variety of methods used in the present study demonstrates that mast cells in the rat brain transcribe the GnRH-I gene and that translation can be detected using antisera to GnRH-I and GAP. In addition, the number of mast cells increases in the brain in response to a behavioral stimulus, and the proportion of GnRH-I-IR mast cells is maintained. What role mast cellderived GnRH-I might play in the thalamus, especially during times of mast cell number increase, is unknown. This work points to a novel mechanism of interaction between the cells of the immune and central nervous systems, in which non-neuronal effector cells such as mast cells are directed to specific areas of the brain and potentially affect both CNS and immune system function.
